U S data for AstraZeneca's COVID-19 vaccine under review
Long-awaited results from AstraZeneca Plc’s U.S coronavirus vaccine trial are currently being reviewed by independent advisors to determine whether the shot is safe and effective. Dr Francis Collins, director of the National Institutes of Health (NIH), said the drug company and its partner, the University of Oxford, completed enrollment of 30,000 participants earlier this year. … Read more